Full Bodybuilder Panel

Liver enzyme baseline and monitoring.

Ref: 0 – 40 U/L

Liver enzyme; also elevated by intense training.

Ref: 0 – 40 U/L

Specific liver damage marker.

Ref: 0 – 60 U/L

Total testosterone level.

Ref: 8 – 30 nmol/L

Bioactive testosterone fraction.

Ref: 200 – 600 pmol/L

Estrogen management and AI dosing.

Ref: 40 – 160 pmol/L

Elevated by 19-nor compounds (Tren, Deca).

Ref: 45 – 375 mIU/L

HPTA function indicator.

Ref: 1.5 – 9.3 IU/L

Fertility and HPTA recovery marker.

Ref: 1.5 – 12 IU/L

Polycythemia risk from testosterone/EQ.

Ref: 0.38 – 0.5 L/L

Paired with haematocrit for red cell assessment.

Ref: 130 – 170 g/L

Red blood cell count; rising with testosterone use.

Ref: 4 – 5.5 x10^12/L

Overall lipid health snapshot.

Ref: 0 – 5.5 mmol/L

Cardioprotective cholesterol; suppressed by most AAS.

Ref: 1 – 999 mmol/L

Atherogenic cholesterol; elevated by most AAS.

Ref: 0 – 3.4 mmol/L

Cardiovascular and metabolic health.

Ref: 0 – 2 mmol/L

Kidney function; elevated by creatine and high protein.

Ref: 60 – 110 umol/L

Kidney filtration rate estimate.

Ref: 90 – 999 mL/min/1.73m2

More accurate kidney marker unaffected by muscle mass.

Ref: 0.55 – 1.15 mg/L

Thyroid screening; T3/GH use affects thyroid function.

Ref: 0.4 – 4 mIU/L

Thyroid hormone level for complete thyroid assessment.

Ref: 10 – 22 pmol/L

Systemic inflammation marker.

Ref: 0 – 5 mg/L

Metabolic health; GH and insulin affect glucose.

Ref: 3.5 – 6 mmol/L

3-month average blood sugar for insulin resistance screening.

Ref: 4 – 6 %

Iron stores; can be elevated by polycythemia.

Ref: 30 – 300 ug/L

Prostate health monitoring on androgens.

Ref: 0 – 4 ug/L

GH activity marker; elevated by exogenous GH.

Ref: 11 – 31 nmol/L